A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
Article
Raizer, Jeffrey J, Abrey, Lauren E, Lassman, Andrew B et al. (2010). A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
. NEURO-ONCOLOGY, 12(1), 87-94. 10.1093/neuonc/nop017
Raizer, Jeffrey J, Abrey, Lauren E, Lassman, Andrew B et al. (2010). A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
. NEURO-ONCOLOGY, 12(1), 87-94. 10.1093/neuonc/nop017
Raizer, Jeffrey J; Abrey, Lauren E; Lassman, Andrew B; Chang, Susan M; Lamborn, Kathleen R; Kuhn, John G; Yung, WK Alfred; Gilbert, Mark R; Aldape, Kenneth D; Wen, Patrick Y; Fine, Howard A; Mehta, Minesh; DeAngelis, Lisa M; Lieberman, Frank; Cloughesy, Timothy F; Robins, H Ian; Dancey, Janet; Prados, Michael D